Valion Bio, Inc. Diluted Shares Outstanding (Weighted Average)
Valion Bio, Inc. (VBIO) reported Diluted Shares Outstanding (Weighted Average) of 881.29 thousand shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-08-14
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 881.29K shares, a 273.64% increase year-over-year.
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 596.37K shares, a 590.74% increase year-over-year.
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was -10.54M shares.
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 6.19M shares, a 420.34% increase year-over-year.
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 287.37K shares, a 516.01% increase from fiscal 2023.
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 46.65K shares, a 51.80% decline from fiscal 2022.
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 96.78K shares, a 97.23% decline from fiscal 2021.
- Valion Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 3.49M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 1 month | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 881.29K shares 10-Q · filed 2025-08-14 | 739.62K shares 10-Q · filed 2025-08-14 | -3.02M shares derived: average of 3 quarters · filed 2025-08-14 | -718.89K shares derived: average of 4 quarters · filed 2025-08-14 | |||||
| 2025-03-31 | 596.37K shares 10-Q · filed 2025-05-15 | -4.97M shares derived: average of 2 quarters · filed 2025-05-15 | -1.25M shares derived: average of 3 quarters · filed 2025-05-15 | -880.24K shares derived: average of 4 quarters · filed 2025-08-14 | |||||
| 2024-12-31 | -10.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -2.18M shares derived: average of 2 quarters · filed 2025-03-21 | -1.37M shares derived: average of 3 quarters · filed 2025-08-14 | 287.37K shares 10-K · filed 2025-03-21 | |||||
| 2024-09-30 | 6.19M shares 10-Q · filed 2024-11-14 | 3.21M shares derived: average of 2 quarters · filed 2025-08-14 | 3.90M shares 10-Q · filed 2024-11-14 | 1.25M shares derived: average of 4 quarters · filed 2025-08-14 | |||||
| 2024-06-30 | 235.87K shares 10-Q · filed 2025-08-14 | 4.01M shares 10-Q · filed 2024-08-14 | 161.10K shares 10-Q · filed 2025-08-14 | 2.74M shares 10-Q · filed 2024-08-14 | -396.63K shares derived: average of 3 quarters · filed 2025-08-14 | -14.25 shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | 86.34K shares 10-Q · filed 2025-05-15 | 1.47M shares 10-Q · filed 2024-05-15 | -712.87K shares derived: average of 2 quarters · filed 2025-05-15 | -78.64K shares derived: average of 3 quarters · filed 2025-05-15 | 15.21K shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -1.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -161.13K shares derived: average of 2 quarters · filed 2025-03-21 | -8.49K shares derived: average of 3 quarters · filed 2025-03-21 | 46.65K shares 10-K · filed 2025-03-21 | 793.04K shares 10-K · filed 2024-03-25 | ||||
| 2023-09-30 | 1.19M shares 10-Q · filed 2024-11-14 | 743.30K shares derived: average of 2 quarters · filed 2024-11-14 | 566.23K shares 10-Q · filed 2024-11-14 | 446.20K shares derived: average of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | 296.78K shares 10-Q · filed 2024-08-14 | 29.68M shares 10-Q · filed 2023-08-14 | 249.26K shares 10-Q · filed 2024-08-14 | 24.93M shares 10-Q · filed 2023-08-14 | 198.32K shares derived: average of 3 quarters · filed 2024-08-14 | 172.94K shares derived: average of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | 201.22K shares 10-Q · filed 2024-05-15 | 20.12M shares 10-Q · filed 2023-05-15 | 149.10K shares derived: average of 2 quarters · filed 2024-05-15 | 131.66K shares derived: average of 3 quarters · filed 2024-05-15 | 2.50M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 96.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 96.88K shares derived: average of 2 quarters · filed 2024-03-25 | 3.27M shares derived: average of 3 quarters · filed 2024-03-25 | 96.78K shares 10-K · filed 2024-03-25 | 9.67M shares 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | 96.78K shares 10-Q · filed 2023-11-14 | 9.68M shares 10-Q · filed 2022-11-14 | 4.86M shares derived: average of 2 quarters · filed 2023-11-14 | 96.71K shares 10-Q · filed 2023-11-14 | 9.67M shares 10-Q · filed 2022-11-14 | 6.53M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 9.62M shares 10-Q · filed 2023-08-14 | 9.67M shares 10-Q · filed 2023-08-14 | 8.67M shares derived: average of 3 quarters · filed 2023-08-14 | 7.15M shares derived: average of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | 9.72M shares 10-Q · filed 2023-05-15 | 8.20M shares derived: average of 2 quarters · filed 2023-05-15 | 6.33M shares derived: average of 3 quarters · filed 2023-05-15 | 5.34M shares derived: average of 4 quarters · filed 2023-05-15 | |||||
| 2022-01-31 | 9.72M shares 10-Q · filed 2022-05-16 | ||||||||
| 2021-12-31 | 6.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 4.63M shares derived: average of 2 quarters · filed 2023-03-31 | 3.88M shares derived: average of 3 quarters · filed 2023-03-31 | 3.49M shares 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | 2.58M shares 10-Q · filed 2022-11-14 | 2.48M shares derived: average of 2 quarters · filed 2022-11-14 | 2.43M shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 2.37M shares 10-Q · filed 2022-08-15 | 2.35M shares 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | 2.33M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |